Why Shares of Protagonist Therapeutics Rose This Week
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
What happened
Shares of Protagonist Therapeutics (NASDAQ: PTGX) rose by 23.3% for the week, as of Thursday afternoon, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech company’s stock closed last week at $18.74 and rose to as high as $23.74
Shares of Protagonist Therapeutics (NASDAQ: PTGX) rose by 23.3% for the week, as of Thursday afternoon, according to data provided by S&P Global Market Intelligence. The clinical-stage biotech company’s stock closed last week at $18.74 and rose to as high as $23.74
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1116617012-6a8112931e6f4375b6e1481b39eeeae8.jpg "How to Become a Real Estate Agent: A Step-by-Step Guide")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1255077848-13fe034d27ba4d1398930d76d7be6693.jpg "6 Best Paying Jobs in Finance")